Cash from Operations (TTM) Chart

View Cash from Operations (TTM) for CBSC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (TTM) Chart
Start Trial

Historical Cash from Operations (TTM) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 -0.6874M
March 31, 2026 -0.6367M
December 31, 2025
September 30, 2025
June 30, 2025
March 31, 2025
December 31, 2024 -1.056M
September 30, 2024 -0.9749M
June 30, 2024 -1.16M
March 31, 2024 -1.245M
December 31, 2023 -0.8608M
September 30, 2023 -1.028M
June 30, 2023 -1.074M
March 31, 2023 -1.187M
December 31, 2022 12.49M
September 30, 2022 12.50M
June 30, 2022 12.78M
March 31, 2022 12.99M
December 31, 2021 -0.8886M
Date Value
September 30, 2021 -0.7046M
June 30, 2021 -0.4845M
March 31, 2021 -0.6626M
December 31, 2020 -0.9491M
September 30, 2020
June 30, 2020
March 31, 2020
December 31, 2019
September 30, 2019
June 30, 2019 -0.1777M
March 31, 2019 -0.1087M
December 31, 2018 -0.7151M
September 30, 2018 -0.9101M
June 30, 2018 -0.6999M
March 31, 2018 -0.7687M
December 31, 2017 -0.0726M
September 30, 2017 0.0579M
June 30, 2017 -0.0506M
March 31, 2017 -0.0625M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

View Cash from Operations (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (TTM) Benchmarks

View Cash from Operations (TTM) Benchmarks
Start Trial
Vyome Holdings, Inc. 0.5245M
Abbott Laboratories 9.905B
AngioDynamics, Inc. 3.089M
Alphatec Holdings, Inc. 56.52M
AtriCure, Inc. 64.94M